A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants with Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) - The BiRCh Study Meeting Abstract

publication date

  • February 1, 2026

webpage

published in

volume

  • 157

issue

  • 2